197 related articles for article (PubMed ID: 19957378)
21. Inhibition of bladder tumour growth by histone deacetylase inhibitor.
Ozawa A; Tanji N; Kikugawa T; Sasaki T; Yanagihara Y; Miura N; Yokoyama M
BJU Int; 2010 Apr; 105(8):1181-6. PubMed ID: 19681894
[TBL] [Abstract][Full Text] [Related]
22. The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells.
Fedier A; Dedes KJ; Imesch P; Von Bueren AO; Fink D
Int J Oncol; 2007 Sep; 31(3):633-41. PubMed ID: 17671692
[TBL] [Abstract][Full Text] [Related]
23. Valproic acid exhibits biphasic effects on apoptotic cell death of activated lymphocytes through differential modulation of multiple signaling pathways.
Chen Q; Ouyang DY; Geng M; Xu LH; Zhang YT; Wang FP; He XH
J Immunotoxicol; 2011; 8(3):210-8. PubMed ID: 21457087
[TBL] [Abstract][Full Text] [Related]
24. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM
Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934
[TBL] [Abstract][Full Text] [Related]
25. Pharmacologic resuscitation: cell protective mechanisms of histone deacetylase inhibition in lethal hemorrhagic shock.
Butt MU; Sailhamer EA; Li Y; Liu B; Shuja F; Velmahos GC; DeMoya M; King DR; Alam HB
J Surg Res; 2009 Oct; 156(2):290-6. PubMed ID: 19665733
[TBL] [Abstract][Full Text] [Related]
26. Low dosed interferon alpha augments the anti-tumor potential of histone deacetylase inhibition on prostate cancer cell growth and invasion.
Hudak L; Tezeeh P; Wedel S; Makarević J; Juengel E; Tsaur I; Bartsch G; Wiesner C; Haferkamp A; Blaheta RA
Prostate; 2012 Dec; 72(16):1719-35. PubMed ID: 22473339
[TBL] [Abstract][Full Text] [Related]
27. Teratogenic effects mediated by inhibition of histone deacetylases: evidence from quantitative structure activity relationships of 20 valproic acid derivatives.
Eikel D; Lampen A; Nau H
Chem Res Toxicol; 2006 Feb; 19(2):272-8. PubMed ID: 16485903
[TBL] [Abstract][Full Text] [Related]
28. Gene expression profiling and functional assays of activated hepatic stellate cells suggest that myocardin has a role in activation.
Shimada H; Ochi T; Imasato A; Morizane Y; Hori M; Ozaki H; Shinjo K
Liver Int; 2010 Jan; 30(1):42-54. PubMed ID: 19793196
[TBL] [Abstract][Full Text] [Related]
29. [Inhibitory effect of valproic acid on xenografted Kasumi-1 tumor growth in nude mouse and its mechanism].
Liu P; Tian X; Shi GR; Jiang FY; Liu BQ; Zhang ZH; Zhao L; Yan LN; Liang ZQ; Hao CL
Zhonghua Xue Ye Xue Za Zhi; 2011 Jul; 32(7):458-62. PubMed ID: 22213865
[TBL] [Abstract][Full Text] [Related]
30. Histone deacetylase inhibitors suppress transdifferentiation of gonadotrophs to prolactin cells and proliferation of prolactin cells induced by diethylstilbestrol in male mouse pituitary.
Tun N; Shibata Y; Soe MT; Htun MW; Koji T
Histochem Cell Biol; 2019 Apr; 151(4):291-303. PubMed ID: 30511269
[TBL] [Abstract][Full Text] [Related]
31. All-trans-retinoic acid ameliorates carbon tetrachloride-induced liver fibrosis in mice through modulating cytokine production.
Hisamori S; Tabata C; Kadokawa Y; Okoshi K; Tabata R; Mori A; Nagayama S; Watanabe G; Kubo H; Sakai Y
Liver Int; 2008 Nov; 28(9):1217-25. PubMed ID: 18397230
[TBL] [Abstract][Full Text] [Related]
32. Histone deacetylase inhibitors promote osteoblast maturation.
Schroeder TM; Westendorf JJ
J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
[TBL] [Abstract][Full Text] [Related]
33. Gene expression profiling of early hepatic stellate cell activation reveals a role for Igfbp3 in cell migration.
Mannaerts I; Schroyen B; Verhulst S; Van Lommel L; Schuit F; Nyssen M; van Grunsven LA
PLoS One; 2013; 8(12):e84071. PubMed ID: 24358328
[TBL] [Abstract][Full Text] [Related]
34. Celecoxib induces hepatic stellate cell apoptosis through inhibition of Akt activation and suppresses hepatic fibrosis in rats.
Paik YH; Kim JK; Lee JI; Kang SH; Kim DY; An SH; Lee SJ; Lee DK; Han KH; Chon CY; Lee SI; Lee KS; Brenner DA
Gut; 2009 Nov; 58(11):1517-27. PubMed ID: 19201774
[TBL] [Abstract][Full Text] [Related]
35. Valproic acid inhibits the growth of cervical cancer both in vitro and in vivo.
Sami S; Höti N; Xu HM; Shen Z; Huang X
J Biochem; 2008 Sep; 144(3):357-62. PubMed ID: 18515856
[TBL] [Abstract][Full Text] [Related]
36. Valproic acid-mediated neuroprotection in intracerebral hemorrhage via histone deacetylase inhibition and transcriptional activation.
Sinn DI; Kim SJ; Chu K; Jung KH; Lee ST; Song EC; Kim JM; Park DK; Kun Lee S; Kim M; Roh JK
Neurobiol Dis; 2007 May; 26(2):464-72. PubMed ID: 17398106
[TBL] [Abstract][Full Text] [Related]
37. Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors.
Cho HH; Park HT; Kim YJ; Bae YC; Suh KT; Jung JS
J Cell Biochem; 2005 Oct; 96(3):533-42. PubMed ID: 16088945
[TBL] [Abstract][Full Text] [Related]
38. Effect of histone deacetylase inhibitor on epithelial-mesenchymal transition of liver fibrosis.
Ramzy MM; Abdelghany HM; Zenhom NM; El-Tahawy NF
IUBMB Life; 2018 Jun; 70(6):511-518. PubMed ID: 29601129
[TBL] [Abstract][Full Text] [Related]
39. Anti-leukemic activity of valproic acid and imatinib mesylate on human Ph+ ALL and CML cells in vitro.
Kircher B; Schumacher P; Petzer A; Hoflehner E; Haun M; Wolf AM; Nachbaur D; Gastl G
Eur J Haematol; 2009 Jul; 83(1):48-56. PubMed ID: 19226363
[TBL] [Abstract][Full Text] [Related]
40. Valproic acid-mediated neuroprotection in retinal ischemia injury via histone deacetylase inhibition and transcriptional activation.
Zhang Z; Qin X; Tong N; Zhao X; Gong Y; Shi Y; Wu X
Exp Eye Res; 2012 Jan; 94(1):98-108. PubMed ID: 22143029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
